Mark W. Gossett

Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA.

Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA.

Sanofi-Aventis Australia Pty Ltd. discovers, develops and distributes therapeutic solutions. It provides prescription medicines for the treatment of various chronic health conditions, including type 1 and type 2 diabetes, various cancers, cardiovascular diseases, osteoporosis. The firm also offers influenza, poliomyelitis and paediatric combination, meningococcal and travel vaccines. The company was founded in 1973 and is headquartered in Macquarie Park, Australia.

Relevare Aust Pty Ltd. develops innovative methods to treat diseases. The company was founded on August 9, 2004 and is headquartered in Abbotsford, Australia.

Janssen Biotech, Inc. engages in the development and marketing of prescription drugs. The company is headquartered in Horsham, PA.

Relevare Pharmaceuticals Ltd. develops novel therapies to treat chronic and acute pain. It gives treatment for acute or chronic severe pain and orally available NK1 antagonist combination therapies for the treatment of inflammatory and neuropathic pain. The company was founded in 2003 and is headquartered in Melbourne, Australia.